These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7836774)

  • 1. Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1.
    Martin S; Rieckmann P; Melchers I; Wagner R; Bertrams J; Voskuyl AE; Roep BO; Zielasek J; Heidenthal E; Weichselbraun I
    J Immunol; 1995 Feb; 154(4):1951-5. PubMed ID: 7836774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure.
    Mrowka C; Sieberth HG
    Clin Nephrol; 1995 May; 43(5):288-96. PubMed ID: 7543387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A form of circulating ICAM-1 in human serum.
    Rothlein R; Mainolfi EA; Czajkowski M; Marlin SD
    J Immunol; 1991 Dec; 147(11):3788-93. PubMed ID: 1682385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in Psoriasis.
    Griffiths CE; Boffa MJ; Gallatin WM; Martin S
    Acta Derm Venereol; 1996 Jan; 76(1):2-5. PubMed ID: 8721479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection.
    Lang T; Krams SM; Villanueva JC; Cox K; So S; Martinez OM
    Transplantation; 1995 Feb; 59(4):584-9. PubMed ID: 7533349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating adhesion molecules in tuberculosis.
    Lai CK; Wong KC; Chan CH; Ho SS; Chung SY; Haskard DO; Lai KN
    Clin Exp Immunol; 1993 Dec; 94(3):522-6. PubMed ID: 7504602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.
    Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
    Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble adhesion molecules in juvenile rheumatoid arthritis.
    Bloom BJ; Miller LC; Tucker LB; Schaller JG; Blier PR
    J Rheumatol; 1999 Sep; 26(9):2044-8. PubMed ID: 10493690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus.
    Mrowka C; Sieberth HG
    Clin Investig; 1994 Oct; 72(10):762-8. PubMed ID: 7532481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
    Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
    Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.
    Harning R; Mainolfi E; Bystryn JC; Henn M; Merluzzi VJ; Rothlein R
    Cancer Res; 1991 Sep; 51(18):5003-5. PubMed ID: 1680025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis.
    Voskuyl AE; Martin S; Melchers L; Zwinderman AH; Weichselbraun I; Breedveld FC
    Br J Rheumatol; 1995 Apr; 34(4):311-5. PubMed ID: 7540479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patients.
    Pino-Otín MR; Viñas O; de la Fuente MA; Juan M; Font J; Torradeflot M; Pallarés L; Lozano F; Alberola-Ila J; Martorell J
    J Immunol; 1995 Mar; 154(6):3015-24. PubMed ID: 7876564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis.
    Cush JJ; Rothlein R; Lindsley HB; Mainolfi EA; Lipsky PE
    Arthritis Rheum; 1993 Aug; 36(8):1098-102. PubMed ID: 8102057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids.
    Cengizlier R; Demirpolat E; Tülek N; Cakmak F
    Ann Allergy Asthma Immunol; 2000 May; 84(5):539-41. PubMed ID: 10831009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating ICAM-1 in sera of renal allograft recipients in monitoring of acute rejection].
    Fu Y; Wang M; Ji X
    Zhonghua Yi Xue Za Zhi; 1998 Jun; 78(6):452-3. PubMed ID: 10923510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis.
    Kaufmann P; Tilz GP; Smolle KH; Demel U; Krejs GJ
    Immunobiology; 1996 Jul; 195(2):209-19. PubMed ID: 8877397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.
    Cellier C; Patey N; Fromont-Hankard G; Cervoni JP; Leborgne M; Chaussade S; Barbier JP; Brousse N
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1197-203. PubMed ID: 9471026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.